METAVIA INC. Liabilities Assumed
METAVIA INC. (MTVA) reported Liabilities Assumed of $1.54 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2020-03-30
- METAVIA INC. liabilities assumed for the quarter ending 2018-03-31 was $144.00K, a 2.04% decline year-over-year.
- METAVIA INC. liabilities assumed for the quarter ending 2017-09-30 was $86.00K.
- METAVIA INC. liabilities assumed for the quarter ending 2017-06-30 was -$144.00K, a 120.93% decline year-over-year.
- METAVIA INC. liabilities assumed for the quarter ending 2017-03-31 was $147.00K, a 219.57% increase year-over-year.
- METAVIA INC. liabilities assumed for fiscal 2019 was $1.54M.
| Period end | Liabilities Assumed 3 month | Liabilities Assumed 6 month | Liabilities Assumed 9 month | Liabilities Assumed 12 month |
|---|---|---|---|---|
| 2019-12-31 | $1.54M 10-K · filed 2020-03-30 | |||
| 2018-03-31 | $144.00K 10-Q · filed 2019-05-09 | |||
| 2017-09-30 | $86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$58.00K derived: sum of 2 quarters · filed 2018-11-08 | $89.00K 10-Q · filed 2018-11-08 | |
| 2017-06-30 | -$144.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $3.00K 10-Q · filed 2018-08-14 | ||
| 2017-03-31 | $147.00K 10-Q · filed 2018-05-08 | |||
| 2016-09-30 | -$731.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$43.00K derived: sum of 2 quarters · filed 2017-08-14 | $3.00K 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $688.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $734.00K 10-Q · filed 2017-08-14 | ||
| 2016-03-31 | $46.00K 10-Q · filed 2017-05-10 | |||
| 2015-09-30 | $538.00K 10-Q · filed 2016-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |